☆ 4.2 Article

Upregulated myocardial CXCR4-expression after myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI

JOURNAL OF NUCLEAR CARDIOLOGY (2016)

Journal

JOURNAL OF NUCLEAR CARDIOLOGY

Volume 23, Issue 1, Pages 131-133

Publisher

SPRINGER

DOI: 10.1007/s12350-015-0347-5

Keywords

-

Categories

Cardiac & Cardiovascular Systems Radiology, Nuclear Medicine & Medical Imaging

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Radiology, Nuclear Medicine & Medical Imaging

CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors-a comprehensive analysis of imaging findings and comparison with histopathology

Niklas Dreher, Stefanie Hahner, Carmina T. Fuss, Wiebke Schloetelburg, Philipp E. Hartrampf, Sebastian E. Serfling, Andreas Schirbel, Samuel Samnick, Takahiro Higuchi, Alexander Weich, Constantin Lapa, Andreas Rosenwald, Andreas K. Buck, Stefan Kircher, Rudolf A. Werner

Summary: This study aimed to characterize the in-vivo CXCR4 expression in patients with solid tumors and compare it to ex-vivo findings. The results showed that a substantial proportion of prevalent solid tumors demonstrated increased and uniform [(68)Ga]Ga-pentixafor uptake, indicating high image contrast. Additionally, a fraction of patients with [(68)Ga]Ga-pentixafor-positive tumor burden were potentially suitable for CXCR4-directed therapy.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

Add to Collection

Review Oncology

The Role of [68Ga]Ga-Pentixafor PET/CT or PET/MRI in Lymphoma: A Systematic Review

Domenico Albano, Francesco Dondi, Francesco Bertagna, Giorgio Treglia

Summary: Preliminary evidence suggests that [Ga-68]Ga-Pentixafor PET/CT or PET/MRI may have a useful impact in lymphoma, particularly in FDG-not-avid variants. This systematic review aimed to analyze published data on the role of [Ga-68]Ga-Pentixafor PET/CT or PET/MRI in lymphoma, with a focus on different lymphoma variants and clinical applications. The findings indicate that [Ga-68]Ga-Pentixafor PET can be considered a valuable imaging method for staging and evaluating treatment response in multiple lymphomas, including MZL, CNSL, and LPL. There is also evidence to suggest that [Ga-68]Ga-Pentixafor PET may have better diagnostic performance than [F-18]FDG PET in assessing lymphomas.

CANCERS (2022)

Add to Collection

Article Medicine, General & Internal

Wnt/beta-Catenin Signaling Regulates CXCR4 Expression and [Ga-68] Pentixafor Internalization in Neuroendocrine Tumor Cells

Alexander Weich, Dorothee Rogoll, Sophia Gawlas, Lars Mayer, Wolfgang Weich, Judit Pongracz, Theodor Kudlich, Alexander Meining, Michael Scheurlen

Summary: Loss of Somatostatin Receptor 2 (SSTR2) expression and rising CXC Chemokine Receptor Type 4 (CXCR4) expression are associated with dedifferentiation in neuroendocrine tumors (NET). Activation of Wnt/beta-catenin signaling may promote a more aggressive phenotype in NET. Modulation of the Wnt pathway influences CXCR4 expression and function in NET cell lines, suggesting it may enhance the efficacy of CXCR4-directed therapies or inhibit CXCR4-dependent proliferative signaling.

DIAGNOSTICS (2021)

Add to Collection

Article Multidisciplinary Sciences

A dataset of [ 68 Ga]Ga-Pentixafor PET/CT images of patients with high-grade Glioma

Hessamoddin Roustaei, Nasim Norouzbeigi, Habibeh Vosoughi, Kamran Aryana

Summary: This study presents the results of single-center prospective information on the targeting of chemokine receptor -4 (CXCR4) in high-grade glial brain tumors using a radiolabeled PET tracer. High-grade glioma is a highly resistant malignancy and has a low overall 5-year survival rate. CXCR4 is overexpressed in high-grade gliomas and can be targeted for imaging. PET/CT imaging was conducted in 24 treatment-naive patients using a novel radiotracer, and the images were analyzed with advanced algorithms.

DATA IN BRIEF (2023)

Add to Collection

Article Medicine, Research & Experimental

CXCR4 PET imaging of mantle cell lymphoma using [68Ga]Pentixafor: comparison with [18F]FDG-PET

Marius E. Mayerhoefer, Markus Raderer, Wolfgang Lamm, Verena Pichler, Sarah Pfaff, Michael Weber, Barbara Kiesewetter, Markus Hacker, Lukas Kazianka, Philipp B. Staber, Hans-Juergen Wester, Johannes Rohrbeck, Ingrid Simonitsch-Klupp, Alexander Haug

Summary: In this prospective study, [Ga-68]Pentixafor-PET showed higher sensitivity and detection rates compared to [F-18]FDG-PET in patients with mantle cell lymphoma (MCL), indicating that it may be a potential alternative for imaging in these patients. The study also found that SUVs and TBRs were significantly higher for [Ga-68]Pentixafor-PET, with the most notable difference observed in mean TBRblood values.

THERANOSTICS (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Functional nodules in primary aldosteronism: identification of CXCR4 expression with 68Ga-pentixafor PET/CT

Yinjie Gao, Jie Ding, Yunying Cui, Tianyi Li, Hao Sun, Dachun Zhao, Yushi Zhang, Li Huo, Anli Tong

Summary: Ga-68-pentixafor PET/CT shows high sensitivity and specificity in the diagnosis of functional nodules in primary aldosteronism. It performs better in detecting nodules with a diameter greater than 1 cm.

EUROPEAN RADIOLOGY (2023)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [68Ga]Ga-Pentixafor/[177Lu]Lu-Pentixather

Sarah M. Jacobs, Pieter Wesseling, Bart de Keizer, Nelleke Tolboom, F. F. Tessa Ververs, Gerard C. Krijger, Bart A. Westerman, Tom J. Snijders, Pierre A. Robe, Anja G. van der Kolk

Summary: CXCR4 is found to be overexpressed in multiple human cancer types but is low or absent in healthy tissue. In glioblastoma, it is associated with poor prognosis. The study aimed to investigate CXCR4 expression in glioblastoma tissue using PET agents and found a subset of tumors with high CXCR4 expression may be good candidates for targeted radionuclide therapy.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

[68Ga]Ga-Pentixafor PET/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors' density by immunochemistry techniques

Ankit Watts, Baljinder Singh, Harmandeep Singh, Amanjit Bal, Harneet Kaur, Ninjit Dhanota, Sunil K. Arora, Bhagwant R. Mittal, Digambar Behera

Summary: In vivo quantification of CXCR4 receptors in different lung cancer sub-types using [Ga-68]Ga-Pentixafor PET/CT showed higher expression in small cell lung cancer patients compared to non-small cell lung cancer and lung neuroendocrine neoplasm patients. The study also demonstrated a significant correlation between SUVmax and MFI values in squamous cell NSCLC and NSCLC adenocarcinoma, supporting the specific in vivo uptake of [Ga-68]Ga-Pentixafor by CXCR4 receptors as a potential tool for response assessment and development of CXCR4-based radioligand therapies in lung cancer.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

Add to Collection

Article Biology

Imaging Inflammation in Atherosclerosis with CXCR4-Directed [68Ga]PentixaFor PET/MRI-Compared with [18F]FDG PET/MRI

Xia Lu, Raffaella Calabretta, Wolfgang Wadsak, Alexander R. Haug, Marius Mayerhoefer, Markus Raderer, Xiaoli Zhang, Jingle Li, Marcus Hacker, Xiang Li

Summary: This study compared the uptake of [Ga-68]PentixaFor and [F-18]FDG in arterial lesions and found that [Ga-68]PentixaFor PET/MRI identified more lesions and showed higher uptake. It also revealed an increased uptake of [Ga-68]PentixaFor in patients with high-risk cardiovascular factors and a correlation between elevated uptake in active arterial segments and the heart.

LIFE-BASEL (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

A prospective comparative study of [Ga-68]Ga-RM26 and [Ga-68]Ga-PSMA-617 PET/CT imaging in suspicious prostate cancer

Xiaomei Gao, Yongxiang Tang, Minfeng Chen, Jian Li, Hongling Yin, Yu Gan, Xiongbin Zu, Yi Cai, Shuo Hu

Summary: This study compared [Ga-68]Ga-RM26 PET/CT and [Ga-68]Ga-PSMA-617 PET/CT for diagnosing prostate cancer, and found that [Ga-68]Ga-PSMA-617 PET/CT had superior accuracy in detecting clinically significant PCa, while [Ga-68]Ga-RM26 PET/CT showed an advantage for imaging low-risk PCa.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

Add to Collection

Article Oncology

Impact of [Lu-177]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [Ga-68]Ga-PSMA-11-PET/CT

Daniel Groener, Jennifer Wichert, Magdalena Adams, Nicolai Mader, Konrad Klimek, Christina Nguyen Ngoc, Justus Baumgarten, Christian Happel, Philipp Mandel, Felix K. H. Chun, Nikolaos Tselis, Frank Gruenwald, Amir Sabet

Summary: This study aims to assess the change in uptake to reference organs, including the liver, parotid, and salivary glands after radioligand therapy (RLT) with [Lu-177]Lu-PSMA-617 in relation to pretreatment imaging metrics. The results showed that RLT has a significant impact on salivary gland uptake, while the changes in liver uptake are burden-dependent.

CANCERS (2023)

Add to Collection

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Ga-68-DOTANOC PET/CT in Adrenal Schwannoma

Piyush Aggarwal, Harmandeep Singh, Rajender Kumar, Ritambhra Nada, Girdhar S. Bora, Rama Walia

Summary: Adrenal schwannoma is a rare benign tumor arising from the Schwann cells, and differentiating it from malignant adrenal lesions requires a combination of clinical, biochemical, imaging, and histopathological findings. Ga-68-DOTANOC PET/CT is a sensitive imaging modality for detecting adrenal lesions like pheochromocytoma. However, false-positive findings on somatostatin receptor imaging are common due to the expression of somatostatin receptors in both benign and malignant lesions. Here, we present a case of adrenal incidentaloma that showed positive findings on Ga-68-DOTANOC PET, but was confirmed as a benign adrenal spindle cell tumor on histopathology.

CLINICAL NUCLEAR MEDICINE (2023)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Assessment of Central Nervous System Lymphoma Based on CXCR4 Expression In Vivo Using 68Ga-Pentixafor PET/MRI

Angelika M. Starzer, Anna S. Berghoff, Tatjana Traub-Weidinger, Alexander R. Haug, Georg Widhalm, Marcus Hacker, Ivo Rausch, Matthias Preusser, Marius E. Mayerhoefer

Summary: The purpose of this report is to evaluate the feasibility of Ga-68-pentixafor PET for the assessment and follow-up of CNSL. The study showed high accuracy of Ga-68-pentixafor PET in lesion detection, with PTV41% demonstrating the highest concordance with lesion morphology. Future studies should focus on testing the clinical value of Ga-68-pentixafor PET in distinguishing between glioma and CNSL, and between radiation-induced inflammation and viable residual tumor.

CLINICAL NUCLEAR MEDICINE (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Total-body [(68) Ga]Ga-PSMA-11 PET/CT improves detection rate compared with conventional [(68) Ga]Ga-PSMA-11 PET/CT in patients with biochemical recurrent prostate cancer

Yining Wang, Zijun Chen, Yinjie Zhu, Haitao Zhao, Lianghua Li, Gang Huang, Wei Xue, Ruohua Chen, Jianjun Liu

Summary: The purpose of this study was to assess whether total-body [(68) Ga]Ga-PSMA-11 PET/CT could improve the detection rate compared with conventional [(68) Ga]Ga-PSMA-11 PET/CT in patients with biochemical recurrent prostate cancer. The results showed that total-body [(68) Ga]Ga-PSMA-11 PET/CT had better objective evaluation in terms of background noise, lesion prominence, liver SD, SNR, and lesion SUVmax compared with conventional [(68) Ga]Ga-PSMA-11 PET/CT. Overall, total-body [(68) Ga]Ga-PSMA-11 PET/CT had a significantly higher detection rate for biochemical recurrent prostate cancer compared to conventional [(68) Ga]Ga-PSMA-11 PET/CT. Rating: 9/10.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-Pentixafor PET/MRI for Treatment Response Assessment in Mantle Cell Lymphoma Comparison Between Changes in Lesion CXCR4 Expression on PET and Lesion Size and Diffusivity on MRI

Marius E. Mayerhoefer, Markus Raderer, Michael Weber, Wolfgang Lamm, Barbara Kiesewetter, Marcus Hacker, Lukas Nics, Stefan Schmitl, Doris Leithner, Hans-Juergen Wester, Alexander Haug

Summary: The aim of this study was to compare CXCR4 imaging with Ga-68-pentixafor PET to MRI for treatment response assessment in patients with mantle cell lymphoma (MCL). The results indicated that Ga-68-pentixafor PET is superior to MRI for assessing complete remission status in MCL patients, especially at the end of treatment.

CLINICAL NUCLEAR MEDICINE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Imaging of cardiac fibroblast activation in a patient after acute myocardial infarction using 68Ga-FAPI-04

Susan Notohamiprodjo, Stephan G. Nekolla, Stephanie Robu, Alberto Villagran Asiares, Christian Kupatt, Tareq Ibrahim, Karl-Ludwig Laugwitz, Marcus R. Makowski, Markus Schwaiger, Wolfgang A. Weber, Zohreh Varasteh

Summary: This study demonstrated the feasibility of noninvasive imaging of fibroblast activation protein (FAP) expression after myocardial infarction (MI) using Ga-68-FAPI-04-PET, and showed that Ga-68-FAPI-04 uptake extends beyond the actual infarcted area in the infarct territory. Follow-up CMR confirmed the overestimation of the infarct size by Ga-68-FAPI-04 uptake.

JOURNAL OF NUCLEAR CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

Andrew J. Einstein, Cole Hirschfeld, Michelle C. Williams, Joao V. Vitola, Nathan Better, Todd C. Villines, Rodrigo Cerci, Leslee J. Shaw, Andrew D. Choi, Sharmila Dorbala, Ganesan Karthikeyan, Bin Lu, Valentin Sinitsyn, Alexey A. Ansheles, Takashi Kudo, Chiara Bucciarelli-Ducci, Bjarne Linde Norgaard, Pal Maurovich-Horvat, Roxana Campisi, Elisa Milan, Lizette Louw, Adel H. Allam, Mona Bhatia, Lorenzo Sewanan, Eli Malkovskiy, Yosef Cohen, Michael Randazzo, Jagat Narula, Olga Morozova, Thomas N. B. Pascual, Yaroslav Pynda, Maurizio Dondi, Diana Paez

Summary: The study aimed to determine the impact of the COVID-19 pandemic on cardiac testing practices and volumes worldwide, showing recovery rates in high-income countries but stagnation in lower-income countries. Psychological stress among providers was found to affect patient care and recovery of cardiac testing.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Perspectives on translational molecular imaging and therapy: an overview of key questions to be addressed

Fijs W. B. van Leeuwen, Margret Schottelius, Felix M. Mottaghy, Fabien Hyafil, Mark Lubberink, Gabriela Kramer-Marek, Wim J. G. Oyen

EJNMMI RESEARCH (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Multi-center study of inter-rater reproducibility, image quality, and diagnostic accuracy of CZT versus conventional SPECT myocardial perfusion imaging

Nabeel Mansour, Stephan G. Nekolla, Eliana Reyes, George Angelidis, Panagiotis Georgoulias, Constantinos Anagnostopoulos, Paco Bravo, Isabella Bruno, Albert Flotats, Francisco Fuentes-Ocampo, Roberto Sciagra, Felix Keng, Lukas Kessler, Maria Papathanasiou, Prem Soman, Christoph Rischpler

Summary: CZT-MPI has higher diagnostic sensitivity in detecting coronary artery disease compared to conventional Anger-MPI, but it has reduced specificity and diagnostic accuracy. Experienced readers show higher inter-rater agreement and special training is required for non-experienced readers.

JOURNAL OF NUCLEAR CARDIOLOGY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANM

Brett W. Sperry, Timothy M. Bateman, Esma A. Akin, Paco E. Bravo, Wengen Chen, Vasken Dilsizian, Fabien Hyafil, Yiu Ming Khor, Robert J. H. Miller, Riemer H. J. A. Slart, Piotr Slomka, Hein Verberne, Edward J. Miller, Chi Liu

Summary: This article discusses the performance, interpretation, and reporting of hot spot imaging in nuclear cardiology. Hot spot imaging has been an important part of nuclear medicine, especially in oncology or infection indications, and its use in nuclear cardiology is expanding. The article focuses on image acquisition and processing, quantification methods, indications, protocols, and reporting of hot spot imaging.

JOURNAL OF NUCLEAR CARDIOLOGY (2023)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Myocardial perfusion imaging with PET-CT: let's think global!

Fabien Hyafil

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Value of PET ECG gating in a cross-validation study of cardiac function assessment by PET/MR imaging

Alberto Villagran Asiares, Teresa Vitadello, Borjana Bogdanovic, Esteban Lucas Solari, Lachlan McIntosh, Sylvia Schachoff, Tareq Ibrahim, Stephan G. Nekolla

Summary: This study investigated the impact of different cardiac gating methods on the assessment of cardiac function using FDG-PET. The results showed that the PET and MR-based cardiac function parameters were highly correlated, but the selected PET ECG gating method introduced variabilities and led to substantial disagreement in the assessment.

JOURNAL OF NUCLEAR CARDIOLOGY (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms

Bruno Verges, Victor Aboyans, Denis Angoulvant, Pierre Boutouyrie, Bertrand Cariou, Fabien Hyafil, Kamel Mohammedi, Pierre Amarenco

Summary: This review summarizes the potential mechanisms by which glucagon-like peptide-1 receptor agonists (GLP-1RAs) provide stroke protection in patients with diabetes. GLP-1RAs show multiple anti-atherosclerotic effects and reduce traditional stroke risk factors. Additionally, GLP-1RAs demonstrate direct cerebral effects in animal stroke models, promoting neurogenesis and reducing infarct volume.

CARDIOVASCULAR DIABETOLOGY (2022)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

In This Issue of the Journal

Fabien Hyafil, Robert J. J. Gropler

CIRCULATION-CARDIOVASCULAR IMAGING (2023)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM)

Matthias Totzeck, Nicolas Aide, Johann Bauersachs, Jan Bucerius, Panagiotis Georgoulias, Ken Herrmann, Fabien Hyafil, Jolanta Kunikowska, Mark Lubberink, Carmela Nappi, Tienush Rassaf, Antti Saraste, Roberto Sciagra, Riemer H. J. A. Slart, Hein Verberne, Christoph Rischpler

Summary: This article provides an overview of the range and potential side effects of cardiotoxic cancer therapies. It also highlights the promising role of nuclear medicine in the diagnosis of cardiotoxic diseases. Furthermore, it discusses the use of non-nuclear cardiovascular imaging and biomarkers in defining cardiotoxicity, and presents specific suggestions for the application of nuclear imaging techniques in diagnosing cardiotoxicity.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

Add to Collection

Correction Radiology, Nuclear Medicine & Medical Imaging

Correction to: Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM)

Matthias Totzeck, Nicolas Aide, Johann Bauersachs, Jan Bucerius, Panagiotis Georgoulias, Ken Herrmann, Fabien Hyafil, Jolanta Kunikowska, Mark Lubberink, Carmela Nappi, Tienush Rassaf, Antti Saraste, Roberto Sciagra, Riemer H. J. A. Slart, Hein Verberne, Christoph Rischpler

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Preclinical Imaging of Cardiovascular Disesase

Stephan G. Nekolla, Christoph Rischpler, Takahiro Higuchi

Summary: Noninvasive imaging techniques, such as SPECT, PET, CT, echocardiography, or MRI, have become essential in cardiovascular research and offer numerous advantages, such as high sensitivity and reliable quantification. Incorporating SPECT and PET imaging into a well-defined workflow similar to clinical imaging can effectively implement the concept of bench to bedside in cardiology translational research.

SEMINARS IN NUCLEAR MEDICINE (2023)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Influence of corticosteroid treatment on CXCR4 expression in DLBCL

Sebastian Martin, David Viertl, Anna Janz, Stefan Habringer, Ulrich Keller, Margret Schottelius

Summary: This study investigates the influence of corticosteroids on CXCR4 regulation in diffuse large B cell lymphoma (DLBCL). The results show that corticosteroids consistently induce an upregulation of CXCR4 expression in DBLCL cells, suggesting that they do not lead to downregulation of CXCR4 and may even have a beneficiary effect in DLBCL patients prior to [Lu-177]Lu-PentixaTher RLT.

EJNMMI RESEARCH (2023)

Add to Collection

Meeting Abstract Cardiac & Cardiovascular Systems

The Role of Repeated PET/MRI Hybrid Imaging in Pulmonary Arterial Hypertension Patients Receiving Specific Therapy, Four-Year Observation

Remigiusz Kazimierczyk, Piotr Szumowski, Stephan Nekolla, Lukasz Malek, Piotr Blaszczak, Marcin Hladunski, Bozena Sobkowicz, Janusz Mysliwiec, Karol Kaminski

CIRCULATION (2022)

Add to Collection

Meeting Abstract Radiology, Nuclear Medicine & Medical Imaging

Initial Assessment of a Novel Multi-pinhole Collimator on Triple-head SPECT for Cardiovascular Imaging

A. Krizsan, K. Kukuts, W. Al-Muhanna, Z. Szoboszlai, L. Balazs, J. Kiss, S. Nekolla, S. Barna, I. Garai, T. Bukki, A. Forgacs

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.